Clinical Chemistry Analyzers

Content

• 1. Overview
  • 1.1 Objectives of the Report
  • 1.2 Methodology
  • 1.3 Scope of the Report
  • 1.4 Executive Summary
• 2. IVD Clinical Chemistry Market
  • 2.1 Introduction
• 3. IVD Clinical Chemistry Market
  • 3.1 Markets
    • 3.1.1 Global Markets
    • 3.1.2 Global Drivers of Clinical Chemistry Testing
    • 3.1.3 Global Outlook
    • 3.1.4 U.S. Market
    • 3.1.5 European Market
      • 3.1.5.1 German Clinical Chemistry Diagnostic Markets
      • 3.1.5.2 U.K. Clinical Chemistry Testing Diagnostic Market
      • 3.1.5.2.1 U.K. Market Statistics
      • 3.1.5.2.2 U.K. Competitive Analysis
      • 3.1.5.2.3 U.K. Market Access
      • 3.1.5.3 French Clinical Chemistry Diagnostic Market
      • 3.1.5.4 Italian Clinical Chemistry Diagnostic Market
      • 3.1.5.5 Spanish Clinical Chemistry Diagnostic Market
      • 3.1.5.6 Indian Clinical Chemistry Diagnostic Market
      • 3.1.5.6.1 India?s In Vitro Diagnostic Testing Industry
      • 3.1.5.7 Scandinavian Clinical Chemistry Market
      • 3.1.5.8 Japanese Clinical Chemistry Testing Market
      • 3.1.5.9 Country Clinical Chemistry Smaller Markets
      • 3.1.5.9.1 Chinese Clinical Chemistry Market
      • 3.1.5.9.2 Canada Clinical Chemistry Market
      • 3.1.5.9.3 Brazil Clinical Chemistry Market
      • 3.1.5.9.4 Turkey Clinical Chemistry Market
      • 3.1.5.9.5 Australia Clinical Chemistry Market
      • 3.1.5.9.6 Mexico IVD Market
      • 3.1.5.10 Remaining World Clinical Chemistry Testing Market
      • 3.1.5.11 Overview of Asian Healthcare Market
      • 3.1.5.11.1 Singapore
      • 3.1.5.11.2 Malaysia
      • 3.1.5.11.3 Thailand
      • 3.1.5.11.4 Indonesia
      • 3.1.5.11.5 Philippines
      • 3.1.5.11.6 South Korea
      • 3.1.5.11.7 India
      • 3.1.5.11.8 Hong Kong
      • 3.1.5.11.9 Taiwan
      • 3.1.5.12 Overview of the Latin American Diagnostics Market
  • 3.2 Clinical Chemistry Sector
    • 3.2.1 Industry-Served Markets
    • 3.2.2 Industry Players
      • 3.2.2.1 Manufacturing Companies
    • 3.2.3 Market Specialization
    • 3.2.4 Revenue and Reimbursement
    • 3.2.5 Companies
  • 3.3 Outlook for Clinical Chemistry Testing
    • 3.3.1 Long-Term Changes
    • 3.3.2 Market Drivers
    • 3.3.3 The Limits to Growth
    • 3.3.4 Hot Sectors in the IVD Market
    • 3.3.5 Key Technologies
    • 3.3.6 Conclusion
• 4. Clinical Chemistry Instrument Market by Sector: Size, Growth, Share and Competitors
  • 4.1 Ultra-Large Throughput Chemistry Analyzers
  • 4.2 Large-Throughput Analyzers
  • 4.3 Mid-Size Clinical Chemistry Analyzers
  • 4.4 Chemistry Analyzers for the Small-Volume Market
• 5. Important Technology Trends
  • 5.1 Technology Platform Innovations in Point-of-Care Testing
  • 5.2 Sensor Systems for Diagnostic Applications
  • 5.3 Glucose Measurements
  • 5.4 Glucose Test Methods
  • 5.5 Cholesterol Measurements
  • 5.6 The New Paradigm
  • 5.7 Consolidated Workstations
  • 5.8 Automation in the Laboratory in Response to Labor Shortages
  • 5.9 Laboratory Information Systems
  • 5.10 Biosensor Technology
  • 5.11 Data-Management Issues
    • 5.11.1 Wireless LANs
    • 5.11.2 Data and Workflow Management Systems
    • 5.11.3 Beckman Command Central Version 2.0
  • 5.12 Connectivity Platforms
    • 5.12.1 Laboratory Data Linking Software and Interface to the Laboratory Information System
    • 5.12.2 AbbottLink Analyzer Connections
    • 5.12.3 Beckman Coulter DL2000 Data Manager v6.5
    • 5.12.4 bioM?rieux Inc. ENQ
• 6. Business Trends in the Clinical Chemistry Analyzer Sector
  • 6.1 Key Developments
  • 6.2 Sector Consolidation
  • 6.3 Diagnostic Testing Growth Trends
  • 6.4 Reagent and Hardware Business in Japan
  • 6.5 New Products
  • 6.6 Acquisition, License Agreements, Internal Development and Partnerships
  • 6.7 Product Testing Depth in Clinical Chemistry Testing
  • 6.8 Government Regulation
    • 6.8.1 U.S. Regulation
      • 6.8.1.1 Importing Medical Devices to the U.S
      • 6.8.1.2 Exporting Medical Devices from the U.S
    • 6.8.2 U.K. Regulation
    • 6.8.3 E.U. Regulation
    • 6.8.4 Japanese Regulation
    • 6.8.5 Korean Regulation
  • 6.9 Increased Market Penetration
  • 6.10 Costs of Doing Business in Europe
  • 6.11 Drivers of European Diagnostics Testing
  • 6.12 European Reimbursement Practices
  • 6.13 Cost Containment in Europe
  • 6.14 Medicare Reimbursement Trends
• 7. Company Profiles
  • 7.1 Abaxis, Inc
  • 7.2 Abbott Diagnostics
  • 7.3 Adaltis Inc
  • 7.4 Alfa Wasserman, Inc. (f/k/a Electro-Nucleonics, Inc. and Schiapparelli Biosystems, Inc.)
  • 7.5 Awareness Technology, Inc
  • 7.6 Siemens Medical Solutions USA, Inc
  • 7.7 Beckman Coulter, Inc
  • 7.8 Dade Behring, Inc. (Acquired by Siemens Medical Solutions)
  • 7.9 Hitachi, Ltd
  • 7.10 Horiba, Ltd
  • 7.11 JEOL Ltd
  • 7.12 Nova Biomedical Corporation
  • 7.13 Olympus America, Inc
  • 7.14 Ortho-Clinical Diagnostics, Inc
  • 7.15 Roche Diagnostics Corp
  • 7.16 Shimadzu Corporation
  • 7.17 Sysmex Corporation
  • 7.18 Thermo Fisher Scientific Inc
  • 7.19 Vital Scientific B.V
• 8. Clinical Chemistry Testing Sector Trends and Forecasts
  • 8.1 Home Care Analysis
  • 8.2 Non-traditional Collection for Chemistry Testing
  • 8.3 New Systems for Critical-Care and Near-Patient Testing
  • 8.4 Utility of Near-Patient Testing in Critical-Care Settings
  • 8.5 Mergers of Diagnostic Companies
  • 8.6 Information Management Advances
  • 8.7 Test Ordering Patterns
  • 8.8 Patient Satisfaction
  • 8.9 Move Away From Central Laboratory
  • 8.10 Healthcare Cost Controls
  • 8.11 Competition for Services
  • 8.12 Drivers of Clinical Chemistry Testing
  • 8.13 Confluence of New Technology
  • 8.14 New Trends in Clinical Laboratory Testing
    • 8.14.1 Trends in Reimbursement Practices
    • 8.14.2 Managed Care
    • 8.14.3 Changes in Patient Management
    • 8.14.4 Focused Testing
    • 8.14.5 Satellite Facilities
    • 8.14.6 Point-of-Care Testing
    • 8.14.7 Regionalization of Laboratory Care
  • 8.15 New Chemistry Analyzers
  • 8.16 Multiplexing Technology
• 9. Clinical Chemistry Product Introductions
  • 9.1 Clinical Chemistry Analyzer Product Launches
  • 9.2 Clinical Chemistry Reagent Product Launches
• 10. Corporate Directory
• List of Figures
  • Figure 3.1:
  • Figure 6.1:
• List of Tables
  • Table 3.1: The Overall In Vitro Diagnostic Testing Market Worldwide, 2008
  • Table 3.2: Worldwide Distribution of IVD Testing, 2008
  • Table 3.3: Global Clinical Chemistry Revenues, 1998-2012
  • Table 3.4: Worldwide Distribution of Clinical Chemistry Testing, 2006
  • Table 3.5: Thirteen Largest Diagnostic Companies Worldwide, 2007
  • Table 3.6: U.S. Clinical Chemistry Testing Market, 2000-2012
  • Table 3.7: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2008
  • Table 3.8: U.S. Individual Clinical Chemistry Diagnostic Test Markets, 2007
  • Table 3.9: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
  • Table 3.10: European Clinical Laboratory Testing Diagnostics by Country Market Estimates, 2007
  • Table 3.11: European Clinical Chemistry Testing Market, 2000-2008
  • Table 3.12: European Rapid Point of Care Testing by Country Market Estimates, 2008
  • Table 3.13: German Clinical Chemistry Testing Diagnostics Products Market Sales, 2003-2012
  • Table 3.14: The German Patient Care Lab Test Market, 2000-2008
  • Table 3.15: The German Alternate Site Testing Market (POL), 2000-2008
  • Table 3.16: The German Hospital Clinical Chemistry Market, 2000-2008
  • Table 3.17: U.K. Clinical Chemistry Diagnostics Products Market Sales, 2000-2008
  • Table 3.18: Major U.K. IVD Manufacturers
  • Table 3.19: U.S. IVD Manufacturers Doing Business in the U.K
  • Table 3.20: Other European Companies That Manufacture IVD Products in the U.K
  • Table 3.21: French Clinical Chemistry Diagnostics Products Market Sales, 1998-2008
  • Table 3.22: Italian Chemistry Diagnostics Products Market Sales, 1998-2008
  • Table 3.23: Spanish Clinical Chemistry Diagnostics Products Market Sales, 1998-2008
  • Table 3.24: Indian IVD Market, 2006-2012
  • Table 3.25: Number of Automated Clinical Labs in India, 2004-2012
  • Table 3.26: Indian IVD Market, 2008
  • Table 3.27: Indian IVD Market for Instruments and Reagents, 2004-2012
  • Table 3.28: Scandinavian Clinical Chemistry Diagnostics Products Market Sales, 2000-2008
  • Table 3.29: Japan Clinical Chemistry Testing Market, 2000-2008
  • Table 3.30: Chinese Clinical Chemistry Diagnostics Products Market Sales, 2000-2008
  • Table 3.31: Canadian Clinical Chemistry Testing Market, 2000-2008
  • Table 3.32: Brazilian IVD Testing Market, 2000-2008
  • Table 3.33: Brazilian Clinical Chemistry Testing Market, 2000-2008
  • Table 3.34: Turkish Clinical Chemistry Testing Market, 2000-2008
  • Table 3.35: Australian Clinical Chemistry Testing Market, 2000-2008
  • Table 3.36: Mexican IVD Testing Market, 2000-2008
  • Table 3.37: Mexican Clinical Chemistry Testing Market, 2000-2008
  • Table 3.38: The ROW Clinical Chemistry Testing Market, 2000-2008
  • Table 3.39: Estimated Number of Clinical Laboratories in Latin America
  • Table 3.40: Principal Marketers of Automated Clinical Chemistry Instruments
  • Table 4.1: Ultra-Large Clinical Chemistry Analyzers
  • Table 4.2: JEOL Analyzer Comparison
  • Table 4.3: Large Clinical Chemistry Analyzers
  • Table 4.4: Mid-size Clinical Chemistry Analyzers
  • Table 5.1: Normal Glucose Values-Fasting State
  • Table 5.2: Applications for Wireless LAN Technology
  • Table 6.1: Medicare Spending on Clinical Lab Services, 1991-2007
  • Table 6.2: Medicare Part B Spending Per Medicare Enrollee, 1998-2009
  • Table 6.3: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2009
  • Table 7.1: Products Marketed by Abbott in the Diagnostic Market
  • Table 7.2: Products Marketed by Siemens (formerly Dade Behring) in the Diagnostics Market
  • Table 7.3: Clinically-Significant Tests Available From Siemens
  • Table 7.4: Comparison of JEOL Analyzers
  • Table 7.5: VITROS ECiQ Immunodiagnostic System
  • Table 8.1: Medicare Billing Guidelines for Multi-channel Chemistry Tests